Early Phase 1Enrolling by invitationINTERVENTIONAL
Systemic and Topical Geroprotective Rejuvenation Assessed by START/REST Aging Clocks
ClinicalTrials.gov · NCT07888595 · Registry updated: 2026-10-22
- Condition / research focus
- Aging
- Sponsor
- Frontiers in Bioscience Research Institute and Aging
- Countries with listed sites
- United States
- Registry dates and results
- Start: 2026-10-21. Completion: 2028-10-14 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
- Topical anti-aging peptide serum (drug) — also listed as: Ivermectin, Metformin, Hydroxychloroquine, Collagen lysate, Thymoquinone, Urolithin, Acid (local)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
- Frontiers in Bioscience Research Institute in Aging and CancerIrvine, California, United States